NYSE ARCA | ETF
Under normal market conditions, the fund will invest at least 80% of its net assets plus any borrowings for investment purposes in equity securities of companies principally engaged in the health sciences group of industries.
While the fund will invest primarily in companies providing products and services for human health, it may also invest in companies whose products or services relate to the growth or survival of animals and plants.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| UCB | UCB SA | Healthcare | Biotechnology | 3.79% |
| ABT | Abbott Laboratories | Healthcare | Medical Devices | 3.64% |
| MDT | Medtronic PLC | Healthcare | Medical Devices | 3.53% |
| JNJ | Johnson & Johnson | Healthcare | Drug Manufacturers - General | 3.30% |
| LONN | Lonza Group AG | Healthcare | Diagnostics & Research | 2.77% |
| EW | Edwards Lifesciences Corp | Healthcare | Medical Devices | 2.77% |
| MTD | Mettler-Toledo International Inc | Healthcare | Diagnostics & Research | 2.53% |
| XTSLA | BlackRock Cash Funds Treasury SL Agency | 2.50% | ||
| PODD | Insulet Corporation | Healthcare | Medical Devices | 2.28% |
| GEN | Genmab A/S | Other | Other | 2.17% |
| BIIB | Biogen Inc | Healthcare | Drug Manufacturers - General | 2.15% |
| A | Agilent Technologies Inc | Healthcare | Diagnostics & Research | 2.14% |
| COO | The Cooper Companies Inc. | Healthcare | Medical Instruments & Supplies | 2.10% |
| TMO | Thermo Fisher Scientific Inc | Healthcare | Diagnostics & Research | 2.04% |
| NOVO-B | Novo Nordisk A/S | Healthcare | Biotechnology | 2.04% |
| LH | Laboratory Corporation of America Holdings | Healthcare | Diagnostics & Research | 1.99% |
| ROG | Roche Holding AG | Healthcare | Drug Manufacturers - General | 1.94% |
| UNH | UnitedHealth Group Incorporated | Healthcare | Healthcare Plans | 1.89% |
| EXAS | EXACT Sciences Corporation | Healthcare | Diagnostics & Research | 1.85% |
| BSX | Boston Scientific Corp | Healthcare | Medical Devices | 1.85% |